Patents by Inventor Anette Gundertofte

Anette Gundertofte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
    Publication number: 20100120743
    Abstract: A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?HSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome.
    Type: Application
    Filed: December 17, 2009
    Publication date: May 13, 2010
    Applicant: High Point Pharmaceuticals, LLC
    Inventors: Anette Gundertofte, Anker Steen Jorgensen, Gita Camilla Tejlgaard Kampen, Henrik Sune Andersen, Inge Thoger Christensen, John Paul Kilburn
  • 11?-hydroxysteroid dehydrogenase type 1 active compounds
    Patent number: 7700583
    Abstract: A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11?-hydroxy-steroid dehydrogenase type 1 (11?HSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome.
    Type: Grant
    Filed: October 6, 2005
    Date of Patent: April 20, 2010
    Assignee: High Point Pharmaceuticals, LLC
    Inventors: Anette Gundertofte, Anker Steen Jorgensen, Gita Camilla Tejlgaard Kampen, Henrik Sune Andersen, Inge Thoger Christensen, Kilburn Paul John
  • 11beta-hydroxysteroid dehydrogenase type 1 active compounds
    Publication number: 20060089349
    Abstract: A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?HSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome.
    Type: Application
    Filed: October 6, 2005
    Publication date: April 27, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Anette Gundertofte, Anker Jorgensen, Gita, Camilla Kampen, Henrik Andersen, Inge Christensen, John Kilburn